Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment 5. Debunking Myths in the US Healthcare System
Top Ten Searches
aldosteronism contrast dialysis vitamin d bicarbonate arf amyloidosis hypocalcemia renal artery husYour Article Summary
Incidence and predictors of osteonecrosis among cyclosporin- or tacrolimus-treated renal allograft recipients
Rheumatology International, 11/04/09
Takao M et al. – There was a lower incidence of osteonecrosis of the hip and knee in renal allograft recipients treated with cyclosporin or tacrolimus. In the patients treated with improved immunosuppressive regimens, delayed graft function was a significant early predictor of osteonecrosis.
Methods- The subjects were 232 renal allograft recipients who had MRI for osteonecrosis of the hip and knee 3 months or longer after transplant
- Evidence of osteonecrosis was visible on the MRI of 11 recipients (4.7%, 95% confidence interval 2.4–8.3)
- Univariate and multivariate logistic regression analyses indicated that delayed graft function was the most important predictor of osteonecrosis
Today in Transplantation...keeping you current
Receive free subspecialty "5-minute updates" via email
'Normal for Now' or 'At Future Risk': A Double Standard for Selecting Young and Older Living Kidney Donors
American Journal of Transplantation, 03/17/10
Transurethral injection therapy with carbon-coated beads for treatment of recurrent pyelonephritis in kidney transplant patients with vesico-ureteral reflux to the allograft
Clinical Transplantation, 03/16/10
Changes in biochemical parameters on the first day after kidney transplantation: risk factors for nosocomial infection
Chinese Medical Journal, 03/16/10
Article Search
Sponsor


See Latest Articles


